4-(5-Piperidin-4-yl-1,2,4-oxadiazol-3-yl)pyridine, 95.0%, 1g

1-Methyladamantane, 97%, 250mg

(S)-2-Amino-2-(3,4-dimethoxyphenyl)acetic acid, 95%, 500mg

4-Fluoro-3-nitrobenzenesulfonamide, 95.0%, 5g

Triethylene Glycol>99.0%(GC)500g

Trial kit Spectra/Por® Biotech CE, 50000 dalton(s), 1 Piece(s)

2-Fluoro-4-iodobenzonitrile, 97.0%, 10g

Acetonitrile [for Spectrophotometry]>99.5%(GC)100mL

Imidazo[1,2-a]pyridine-8-carboxylic acid hydrochloride, 95.0%, 100g

4-Isopropyl-3,5-dimethoxybenzaldehyde, 98%, 1g

Methyl 2-Hydroxy-3-nitrobenzoate, 97.0%, 5g

1,1-Difluoro-2-isocyanato-ethane, 1g

Methyl 3-hydroxycyclopentanecarboxylate, 95.0%, 1g